![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 13, 2022 1:22:28 AM
I wish they would have layed out a plan, as to what the next steps will be, rather than saying "will no longer support the OTC pink market." It's nice that they added "CGE will continue to explore alternative options to the OTC Pink market", but I wish they would give some context as to what those options are.
Overall, another confusing news release, but I will say this: they still see Aradatum as the cash cow, which is encouraging, that means the right things are happening behind the scenes. They have made it clear that Aradatum is the golden goose, and I'm glad they have. I just hope they don't try any tomfoolery. As GRBO stated, only time will tell.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM